Improving diabetes treatment for breast cancer survivors
Official title: Optimizing diabetes treatment strategies in complex comorbidity
Funded at Icahn School of Medicine at Mount Sinai · NIH-11051853 · Data updated 2026-11-12
This study is looking at the best ways to manage type 2 diabetes for breast cancer survivors, helping to find treatment options that work well for their unique health needs.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | April 1, 2024 |
| Project end | January 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $165,762 |
| NIH project number | 5K08DK137022-02 |
| Project ID | NIH-11051853 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are breast cancer survivors who also have type 2 diabetes.
✕Less likely to help
Patients who do not have a history of breast cancer or do not have type 2 diabetes may not benefit from this research.
What this research studies
This research focuses on optimizing treatment strategies for type 2 diabetes (T2DM) specifically in breast cancer survivors, who often face unique health challenges due to their cancer history. The study aims to develop a simulation model that reflects the natural history and management of T2DM in this population, taking into account factors like age, cancer stage, and previous treatments. By evaluating different treatment approaches, the research seeks to identify the most effective strategies for managing diabetes while considering the potential risks associated with cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better overall health outcomes for breast cancer survivors.
How similar studies have gone: Previous research has shown that tailored treatment strategies for comorbid conditions in cancer survivors can lead to significant improvements in patient outcomes.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Leiter, Amanda Candice — Icahn School of Medicine at Mount Sinai
- Study coordinator: Leiter, Amanda Candice
Related research
Other NIH-funded projects on the same topics.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Bringing WHO HEARTS-D diabetes care into Bangladesh cities
A program to help urban clinics in Bangladesh adopt WHO HEARTS-D guidelines to improve detection, treatment, and control of type 2 diabetes.
-
AI-powered fundus imaging to screen for type 2 diabetes
A mobile AI tool uses eye images to help screen adults for type 2 diabetes in clinics or communities.
-
AI-powered eye imaging to screen for type 2 diabetes with a mobile phone
A plan to use AI on smartphone retinal images to help spot type 2 diabetes early, especially in people who may not have easy access to care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.